Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Covidien to Build Medical Device R&D Center in Shanghai

publication date: Sep 15, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Covidien will build a medical device R&D center in Shanghai’s Caohejing Hi-Tech Park that will be operational by July 2012. The company’s R&D staff in China will jump from 25 at present to over 300 when the 100,000 square foot facility is finished. Covidian, which is headquartered in Dublin, but has most of its managing operations in the US, is comprised of three life science divisions: medical devices, pharmaceuticals and medical products. More details....

Stock Symbol: (NYSE: COV)     Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...